Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis

References

• ColemanALGlaucomaLancet19993541803181010577657
   PubMed Web of Science ®Google Scholar
• MaierPCFunkJSchwarzerGAntesGFalck-YtterYTTreatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trialsBMJ200533113415994659
   PubMed Web of Science ®Google Scholar
• WeigertGFindlOLukschAEffects of moderate changes in intraocular pressure on ocular hemodynamics in patients with primary open-angle glaucoma and healthy controlsOphthalmology20051121337134216024084
   PubMed Web of Science ®Google Scholar
• GordonMOBeiserJABrandtJDThe Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucomaArch Ophthalmol2002120714720 discussion 829–73012049575
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol2002120701713 discussion 829–73012049574
   PubMed Web of Science ®Google Scholar
• VassCHirnCSychaTFindlOBauerPSchmettererLMedical interventions for primary open angle glaucoma and ocular hypertensionCochrane Database Syst Rev2007CD00316717943780
   PubMed Web of Science ®Google Scholar
• HodgeWGLachaineJSteffensenIThe efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic reviewBr J Ophthalmol20089271218156371
   PubMed Web of Science ®Google Scholar
• van der ValkRWebersCASchoutenJSZeegersMPHendrikseFPrinsMHIntraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trialsOphthalmology20051121177118515921747
   PubMed Web of Science ®Google Scholar
• van der ValkRSchoutenJSWebersCAThe impact of a nation-wide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeriesJ Glaucoma20051423924215870608
   PubMed Web of Science ®Google Scholar
• BurrJAzuara-BlancoAAvenellAMedical versus surgical interventions for open angle glaucomaCochrane Database Syst Rev2005CD00439915846712
   PubMed Web of Science ®Google Scholar
• LiNChenXMZhouYWeiMLYaoXTravoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trialsClin Experiment Ophthalmol20063475576417073898
   PubMed Web of Science ®Google Scholar
• DenisPLafumaAKhoshnoodBMimaudVBerdeauxGA metaanalysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapyCurr Med Res Opin20072360160817355741
   PubMed Web of Science ®Google Scholar
• FungATReidSEJonesMPHealeyPRMcCluskeyPJCraigJCMeta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucomaBr J Ophthalmol200791626816956912
   PubMed Web of Science ®Google Scholar
• ChengJWWeiRLMeta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressureClin Ther20083062263218498911
   PubMed Web of Science ®Google Scholar
• American Academy of OphthalmologyPreferred Practice Pattern: Primary open-angle glaucoma2005 http://one.aao.org/CE/PracticeGuidelines/PPP.aspx?sid=ca9ec1b5-2567-4e85-96f6-b6540e5ac5a1Accessed July 6, 2009
   Google Scholar
• SchulzKFChalmersIHayesRJAltmanDGEmpirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA19952734084127823387
   PubMed Web of Science ®Google Scholar
• DevereauxPJMannsBJGhaliWAPhysician interpretations and textbook definitions of blinding terminology in randomized controlled trialsJAMA20012852000200311308438
   PubMed Web of Science ®Google Scholar
• McAlisterFALaupacisAWellsGASackettDLUsers’ Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effectJAMA19992821371137710527185
   PubMed Web of Science ®Google Scholar
• Le HenanffAGiraudeauBBaronGRavaudPQuality of reporting of noninferiority and equivalence randomized trialsJAMA20062951147115116522835
   PubMed Web of Science ®Google Scholar
• PiaggioGElbourneDRAltmanDGPocockSJEvansSJReporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statementJAMA20062951152116016522836
   PubMed Web of Science ®Google Scholar
• MeadeMOGuyattGHCookRJAgreement between alternative classifications of acute respiratory distress syndromeAm J Respir Crit Care Med200116349049311179128
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials198671771883802833
   PubMed Web of Science ®Google Scholar
• SheehePRCombination of log relative risk in retrospective studies of diseaseAm J Public Health Nations Health196656174517505951494
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med2002211539155812111919
   PubMed Web of Science ®Google Scholar
• WhitcupSMCantorLBVanDenburghAMChenKA randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertensionBr J Ophthalmol200387576212488264
   PubMed Web of Science ®Google Scholar
• CantorLBHoopJMorganLWudunnDCatoiraYIntraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertensionBr J Ophthalmol2006901370137316825272
   PubMed Web of Science ®Google Scholar
• CantorLBWuDunnDCortesAHoopJKnottsSOcular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertensionSurv Ophthalmol200449 Suppl 1S12S1815016557
   PubMed Web of Science ®Google Scholar
• KozOGOzsoyAYarangumeliAKoseSKKuralGComparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trialActa Ophthalmol Scand20078583884317680841
   PubMedGoogle Scholar
• HepsenIFOzkayaE24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertensionEye20072145345816543930
   PubMed Web of Science ®Google Scholar
• CelliniMCaramazzaRBonsantoDBernabiniBCamposECProstaglandin analogs and blood-aqueous barrier integrity: a flare cell meter studyOphthalmologica200421831231715334011
   PubMed Web of Science ®Google Scholar
• ParrishRKPalmbergPSheuWPA comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter studyAm J Ophthalmol200313568870312719078
   PubMed Web of Science ®Google Scholar
• ArcieriESSantanaARochaFNGuapoGLCostaVPBlood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trialArch Ophthalmol200512318619215710814
   PubMed Web of Science ®Google Scholar
• TopouzisFMelamedSDanesh-MeyerHA 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionEur J Ophthalmol20071718319017415690
   PubMed Web of Science ®Google Scholar
• CardasciaNVetrugnoMTrabuccoTCantatoreFSborgiaCEffects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucomaCurrent Therapeutic Research200364389400
   PubMed Web of Science ®Google Scholar
• ParmaksizSYukselNKarabasVLOzkanBDemirciGCaglarYA comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucomaEur J Ophthalmol200616738016496249
   PubMed Web of Science ®Google Scholar
• NetlandPALandryTSullivanEKTravoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAm J Ophthalmol200113247248411589866
   PubMed Web of Science ®Google Scholar
• NoeckerRJEarlMLMundorfTKSilversteinSMPhillipsMPComparing bimatoprost and travoprost in black AmericansCurr Med Res Opin2006222175218017076978
   PubMed Web of Science ®Google Scholar
• NoeckerRJEarlMLMundorfTPeaceJWilliamsRDBimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertensionAdv Ther20032012112812836812
   PubMed Web of Science ®Google Scholar
• DirksMSNoeckerRJEarlMRohSSilversteinSMWilliamsRDA 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucomaAdv Ther20062338539416912020
   PubMed Web of Science ®Google Scholar
• GandolfiSSimmonsSTSturmRChenKVanDenburghAMThree-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertensionAdv Ther20011811012111571823
   PubMed Web of Science ®Google Scholar
• NoeckerRSDirksMSChoplinNTBernsteinPBatoosinghALWhitcupSMA six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaAm J Ophthalmol2003135556312504698
   PubMed Web of Science ®Google Scholar
• MundorfTNoeckerRJEarlMA multicenter, investigator–masked, randomized comparison of the IOP-lowering efficacy of bimatoprost 0.03% versus travoprost 0.004% in African Americans with glaucoma or ocular hypertensionInvest Ophthalmol Vis Sci200445E-Abstract 4502
   Web of Science ®Google Scholar
• EyawoOLeeCWRachlisBMillsEJReporting of noninferiority and equivalence randomized trials for major prostaglandins: A systematic survey of the ophthalmology literatureTrials200896919055743
   PubMed Web of Science ®Google Scholar
• SowkaJWGurwoodASKabatAGHandbook of Ocular Disease Management: Review of Optometry2002 http://www.revoptom.com/HANDBOOK/hbhome.htmAccessed July 17, 2009
   Google Scholar
• OwenCGCareyIMde WildeSWhincupPHWormaldRCookDGPersistency with medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994–2005Eye2008 [Epub ahead of print]
   Web of Science ®Google Scholar
• FeldmanRMConjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertensionJ Ocul Pharmacol Ther200319233512648301
   PubMed Web of Science ®Google Scholar
• FriedmanDSHahnSRGelbLDoctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency StudyOphthalmology20081151320132718321582
   PubMed Web of Science ®Google Scholar
• HolloGThe side effects of the prostaglandin analoguesExpert Opin Drug Saf20076455217181451
   PubMed Web of Science ®Google Scholar
• BaudouinCGarcherCHaouatNBronAGastaudPExpression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucomaOphthalmology19941014544607907416
   PubMed Web of Science ®Google Scholar